Drug Pipeline

SHR-A1811 for Injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07196774 A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in… Early-stage or Locally Advanced HER2-positive Breast Cancer Recruiting
Phase 2
NCT07110571 A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as… Gastric Cancer Recruiting
Phase 1
NCT07275242 A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor Solid Tumor Recruiting
Sponsors Running SHR-A1811 for Injection Trials
Suzhou Suncadia Biopharmaceuticals Co., Ltd. (2) Jiangsu HengRui Medicine Co., Ltd. (1)
Disease Areas
Gastric Cancer (1) Breast Cancer (1) HER2-Positive Breast Cancer (1)
Get alerts when SHR-A1811 for Injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free